The 9th International Nanomedicine Conference was held last week in Coogee, Sydney. Some of our researchers were there, showcasing their research and networking with colleagues from near and far.
Last week a group of our scientists were in San Francisco attending The Advances in Neuroblastoma Research (ANR) conference. One of them, Dr Jayne Murray, tells us about it.
A childhood brain cancer called diffuse intrinsic pontine glioma (DIPG) is currently incurable. Our researchers have identified a new treatment that may help change that.
PhD student Kim Hanssen has just presented her work at a scientific meeting in Innsbruck, Austria. She gives us her impressions of her first international conference.
We presented exciting results from preclinical drug testing at a cancer conference this week in the US.
Blood vessels supply the fuel needed for rapid tumour growth and spread. But what happens when the network is disrupted?
In a capital famous for its impressive monuments, last week’s American Association for Cancer Research annual meeting (AACR) was an impressive meeting of minds.
We’re showing innovation leaders our world-class expertise and technology for tailoring treatments for childhood cancer at a business event today.
Tumour biologist and PhD student Walter Muskovic received a grant to support research into brain cancer glioblastoma from the chosen charity for zombie walks around Australia, the Brain Foundation. It must be Halloween.
An exciting topic at the recent ANR2016 research conference for neuroblastoma was research into developing blood tests for cancer cells and cancer DNA.